Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia. (Q43206347)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia. |
scientific article published in February 2010 |
Statements
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia (English)
Angelo M Carella
Anna Garuti
Gabriella Cirmena
Gioacchino Catania
Ilaria Rocco
Claudia Palermo
Gianmatteo Pica
Ivana Pierri
Maurizio Miglino
Marco Gobbi
Franco Patrone
1 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference